Biomarker Assay Development
The Westin San Diego
400 West Broadway
San Diego, CA

Schedule of Presentations:

Monday, January 26, 2009
08:00:00 Registration for Pre-Conference Events*
09:00:00 Chairperson’s Opening Remarks
09:00:00 Pre-Conference Workshop* *Separate Registration Required)
09:05:00 in vivo Discovery and Validation of Biomarkers of Human Drug Response and Resistance Joerg Heyer
09:30:00 Preclinical Biomarker Discovery and Validation for a Small Molecule Inhibitor of MEK Kinase Mark R Lackner
09:55:00 Development of Clinically Relevant Gene Expression Profiles for Prognosis of Early Stage Breast Cancer Richard Bender
10:20:00 Networking Coffee Break
10:40:00 Circulating HER-2/neu, A Biomarker for HER-2 Positive Breast Cancer, from Discovery to Patient Management Walter P. Carney
11:00:00 Pre-Conference Tutorial* (*Separate Registration Required)
11:05:00 Discovery of miRNA-Based Biomarkers for Cancer Søren Møller
11:30:00 Lunch on your own
12:30:00 Cancer Biomarker Discovery in the Context of Personalized Medicine Josip Blonder
12:55:00 Industrialized Proteomics for the Discovery and Validation of Oncology Biomarkers Daniel Chelsky
13:20:00 Metabolite Biomarkers of Prostate Cancer Aggressivity Jeffrey Shuster
13:45:00 Networking Refreshment Break
14:10:00 From Discovery to the Clinic: The Novel DNA Methylation Biomarker, Septin 9, for the Detection of Colorectal Cancer in Blood Shannon Payne
14:35:00 Multiplexed Analysis of Glycan Variation on Serum Proteins Using An Antibody Array for Biomarker Profiling Bryce P Nelson
15:00:00 Close of Workshop
15:00:00 Main Conference : Registration
16:00:00 Welcoming Remarks from Conference Director Julia Boguslavsky
16:10:00 Chairperson’s Opening Remarks
16:15:00 Use of Biomarkers and Translational Science to Accelerate and Improve Oncology Drug Development: Opportunities and Roadblocks J Carl Barrett
16:45:00 To be Announced
17:15:00 Reception with Exhibit and Poster Viewing
Tuesday, January 27, 2009
07:30:00 Sponsored Presentation (Opportunity Available) or Morning Coffee
08:00:00 Opportunities and Challenges of Biomarker Assays in Drug Development Francois Legay
09:00:00 Moving Beyond Fit-for-Purpose: Use of Lean Practices to Accelerate Biomarker Assay Development Russell S Weiner
09:30:00 Multiplexed Biomarker Assay Development Michael Pisano
10:10:00 Coffee Break with Exhibit and Poster Viewing
11:00:00 Application of Intra-Assay Calibration Curves to Quantitate Clinical Biomarker Immunoassays Paul Rhyne
11:30:00 Automated Platforms for Biomarker Analysis: Multiplexing Assays and Case Histories John Allinson
12:00:00 Statistical Issues in the Evaluation of Single and Multi-Plex Biomarker Assays
12:30:00 Lunch on your own
14:00:00 Pre-Analytical and Analytical Considerations for Assay Development Gerard J Davis
14:30:00 Biomarker and Companion Diagnostics Assay Development: An IVD Perspective Thomas Li
15:00:00 Sponsored by Monarch Life Sciences : To Be Announced
15:15:00 Millipore, the Experienced Leader in ‘Fit-for-Purpose’ Biomarker Solutions Ronald R Bowsher
15:30:00 Refreshment Break with Exhibit and Poster Viewing
16:30:00 Assessment of Free-and Total- Drug Concentration in the Development of Biotherapeutic Agents - Analytical and Biological Considerations Scott Fountain
17:00:00 Quantification of “Total” and/or “Free” Target Protein Biomarker: Approaches and Applications Jean W Lee
17:30:00 Target-Related Pharmacodynamic Analysis to Guide Successful Development of Biological Therapies: Novel Biomarker Concepts and Analytical Strategies Miro Venturi
18:00:00 Roundtable Discussions
Wednesday, January 28, 2009
07:30:00 Sponsored Presentation (Opportunity Available) or Morning Coffee
08:30:00 Genomics Technologies for Research and Clinical Applications Don A Baldwin
09:00:00 Low Abundance Protein Biomarker Quantitation Using Immunoaffinity Enrichment And Nanoflow LC-MS/MS Hendrik Neubert
09:30:00 Utilizing a LC/MS/MS (MRM) Quantitative Targeted Biomarker Panel to Elucidate Multiple Biological Changes Simultaneously Jon Butler
10:00:00 Sponsored Presentations : (Opportunities Available)
10:30:00 Coffee Break with Poster and Exhibit Viewing
11:30:00 Validation and Implementation of Flow Cytometric Assay to Evaluate Pharmacodynamic Biomarkers in Clinical Study Dianna Wu
12:00:00 Validating Cell-Based Biomarker Assays Iman Jilani
12:30:00 Lunch on your own
14:00:00 Development and Integration of Biomarkers into Clinically Useful Diagnostics Anne Marie Martin
14:30:00 Moving a New Technology into the Routine Lab: Validation and Education Challenges Lawrence Oliver
15:00:00 Molecular Diagnostics Laboratories (MoDEL): A Program to Support Cancer Biomarker Clinical Assay Development J Milburn Jessup
15:30:00 Networking Refreshment Break
16:00:00 Circulating Tumor Cell Assays: A Prognostic and Predictive Factor For Breast, Prostate And Colon Cancer Herbert A Fritsche
16:30:00 Biomarker Assay Development and Validation: An Epiphany for Drug Development and the Management of Patients with Cancer Martin Fleisher
17:00:00 Close of Conference
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.